Muscle damage: CK and MyoInflammation: Il6 and Il 10
Conditions
Interventions
Group 1: An intensive training is carried out with healthy, sporty (strength and endurance) male and female test persons. All test persons must not take any medication or supplements or have any injur
Sponsors
Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung 2 Molekulare und zelluläre Sportmedizin - Zentrum für präventive Doping Forschung
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: youn healthy men and women
Exclusion criteria
Exclusion criteria: Hormone substitution, including thyroid-hormone therapy BMI >30 smokers unbalanced diet (e.g. vegan) metabolic disorders Treatment with insulin, sulfonylureas, glinides, GLP -1 analogs those in need of treatment cardiac arrhythmias Heart failure (EF<55) Performance limiting PAVK (Fontaine Stadium = II) performance- or traininglimiting Respiratory diseases, performance- or traininglimiting degenerative joint diseases or muscular diseases performance-limiting kidney disease performance-limiting neurological illness oncological diseases in the Prehistory (< 5 years) psychiatric and/or addiction disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intravenous Blood samples (9ml) Analytics of muscle damage: CK, Myo inflammation: Il6 und Il10 Time Points T0 (pre), T1 (+3h), T2 (+24h), T3 (+48h), T4 (+72h) | — |
Secondary
| Measure | Time frame |
|---|---|
| Performance: 1RM back squat 20 sprint Counter Movement Jump Time points T0 (pre), T1 (+3h), T2 (+24h), T3 (+48h), T4 (+72h) | — |
Countries
Germany
Contacts
Public ContactEduard Isenmann
DSHS Köln, Kreislaufforschung und Sportmedizin, Abt.2
Outcome results
None listed